newsfilter
← Latest News
GlobeNewswire·

LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

Lead development candidate selected by Janssen Biotech under research collaboration provides a milestone payment to LAVAStrong balance sheet expected to provide cash runway into 2026 UTRECHT, The Netherlands and